Women with uncommon form of ovarian cancer offered hope with new drugs
Tumours shrank or stopped growing in almost one in three women (31 per cent) with low-grade serous ovarian cancer, which does not respond well to chemotherapy, when taking a combination of avutometinib and defactinib. The drugs work by blocking signals that encourage cancer cells to grow.
Clinical trial offers new hope to women with ovarian cancer
Experts are so excited by the latest findings that they hope the treatment will change practice globally for this type of cancer, as ITV News Reporter Olivia Guthrie reports Women with a type of ovarian cancer that is very difficult to treat have shown ...
Ovarian cancer affects thousands of women in the UK each year and is known as the 'silent killer' because its symptoms can be ...
Irish Star on MSN1d
Ovarian cancer symptoms every woman should know that are often overlookedThe first symptoms of ovarian cancer can be easy to brush off, but being able to identify the signs early on can make a huge ...
Women with a type of ovarian cancer that is very difficult to treat have shown remarkable results on a clinical trial testing ...
Scientists at the University of Oxford have just received funding to create the world's first vaccine for ovarian cancer, a ...
Sadly 11 people die every day from the disease, adding up to around 4,100 ovarian cancer deaths in the UK each year but knowing the most common symptoms and risk factors can help ...
A previvor is essentially someone who has a genetic predisposition to certain cancers, but who may or may not currently have ...
Higher levels of ambient nitrogen dioxide may be linked to an increased incidence of ovarian cancer, while associations with ...
The completion of a new drug application for the combination of avutometinib and defactinib in KRAS-mutant ovarian cancer is ...
Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus ...
This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with additional studies to be conducted in other ...
Janey Godley received an outpouring of love and support from fans as she issued an update and revealed she was now receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback